Unveiling the Therapeutic Potential of Ipomoea Batatas Lam: A Journey From Preclinical Research to Clinical Applications
Abstract
Ipomoea batatas Lam, commonly known as sweet potato, has garnered recognition for its significant therapeutic potential, which can be largely ascribed to its abundant array of bioactive secondary metabolites. Among these phytoconstituents, flavonoids, anthocyanins, carotenoids and terpenoids have been shown to possess notable pharmacological properties through preclinical investigations. Evidence from in vitro studies utilising cell culture models indicates that these compounds exhibit robust antioxidant and anticancer activities, with anthocyanins in particular being reported to inhibit the proliferation of cancer cells. Furthermore, in vivo experiments substantiate the diverse therapeutic efficacy of Ipomoea batatas, revealing its anti-obesity, hypoglycaemic, hepatoprotective and anti-arthritic properties. Advancements in the understanding of these therapeutic attributes have facilitated the progression of extracts from Ipomoea batatas to clinical evaluation with subsequent assessment of safety, toxicity, pharmacokinetics and benefit-risk ratios. The transition from preclinical research to clinical validation accentuates its relevance in the realm of metabolic health, especially in combating obesity, liver dysfunction and diabetes. The successful completion of Phase III clinical trials has resulted in the introduction of plant-based antidiabetic formulations into the market, thereby reinforcing the pharmacological significance of this plant. Nevertheless, despite these promising developments, the complex interactions between the phytoconstituents and their corresponding therapeutic effects warrant further investigation. Continued research in this domain is essential, as it promises not only to enrich the understanding of the medicinal properties of Ipomoea batatas but also to reveal innovative therapeutic applications. Such endeavours will likely establish Ipomoea batatas as an esteemed natural resource within contemporary medicine.
References
Salehi B, Krochmal-Marczak B, Skiba D, Patra JK, Das SK, Das G, Popović-Djordjević JB, Kostić AŽ, Anil Kumar NV, Tripathi A, Al-Snafi AE. Convolvulus plant—a comprehensive review from phytochemical composition to pharmacy. Phytother Res. 2020 Feb;34(2):315–28. doi: 10.1002/ptr.6540.
Namo OAT, Akinbola OJ. Sweet Potato: Production, Nutritional Properties and Diseases. In: Sweet Potato: Production, Nutritional Properties and Diseases. NY, USA: Nova Science Publishers; 2016. p. 1–30.
Willson MF, Whelan CJ. The evolution of fruit color in fleshy-fruited plants. Am Nat. 1990;136(6):790–809. doi: 10.1086/285132.
Pandey SK. Sweet Potato. In: Singh HP, Parthasarathy VA, Nirmal B, Eds. Horticulture Vegetable Science (Vegetables, Tubers & Spice Crops). India: Westville Publishing House; 2007. p. 14–8.
Motsa NM, Modi AT, Mabhaudhi T. Sweet potato (Ipomoea batatas L.) as a drought tolerant and food security crop. S Afr J Sci. 2015;111(11–12):1–8. doi: 10.17159/sajs.2015/20140252.
Swamy KRM. Origin, distribution, taxonomy, botanical description, genetics and cytogenetics, genetic diversity and breeding of sweet potato (Ipomoea batatas (L.) Lam). Int J Dev Res. 2024;14(06):65866–74. doi: 10.37118/ijdr.28381.06.2024.
Alam MK. A comprehensive review of sweet potato (Ipomoea batatas [L.] Lam): Revisiting the associated health benefits. Trends Food Sci Technol. 2021;115:512–29. doi: 10.1016/j.tifs.2021.07.001.
Low JW, Ortis R, Vandamme Z andrade M, Biazin B, Grüneberg WJ. Nutrient-dense orange-fleshed sweetpotato: advances in drought-tolerance breeding and understanding of management practices for sustainable next-generation cropping systems in sub-Saharan Africa. Front Sustain Food Syst. 2020;4:50. doi: 10.3389/fsufs.2020.00050.
Grover M, Ali SZ, Sandhya V, Rasul A, Venkateswarlu B. Role of microorganisms in adaptation of agriculture crops to abiotic stresses. World J Microbiol Biotechnol. 2011;27:1231–40. doi: 10.1007/s11274-010-0572-7.
Andrade M, Barker I, Cole D, Fuentes S, Gruneberg W, Kapinga R, et al. Unleashing the potential of sweetpotato in Sub-Saharan Africa: current challenges and way forward. Lima (Peru): International Potato Center; 2009 Feb 27. doi: 10.13140/RG.2.1.4817.0403.
Bovell-Benjamin AC. Sweet potato: a review of its past, present and future role in human nutrition. Adv Food Nutr Res. 2007;52:1–59. doi: 10.1016/S1043-4526(06)52001-7.
Cartabiano-Leite CE, Porcu OM, de Casas AF. Sweet potato (Ipomoea batatas L. Lam) nutritional potential and social relevance: a review. History. 2020;11:23–40. doi: 10.9790/9622-1006082340.
Noreen S, Niazi MK, Shehzadi S, Ikram A, Arshad MT, Gnedeka KT. Extend the emphasis to encompass sweet potatoes health advantages, industrial applications and nutritional qualities. CyTA J Food. 2024;22(1):2390994. doi: 10.1080/19476337.2024.2390994.
Qin Y, Naumovski N, Ranadheera CS, D'Cunha NM. Nutrition-related health outcomes of sweet potato (Ipomoea batatas) consumption: a systematic review. Food Biosci. 2022;50:102208. doi: 10.1016/j.fbio.2022.102208.
Mohanraj R, Sivasankar S. Sweet potato (Ipomoea batatas [L.] Lam) – a valuable medicinal food: a review. J Med Food. 2014;17(7):733–41. doi: 10.1089/jmf.2013.2818.
Wang S, Nie S, Zhu F. Chemical constituents and health effects of sweet potato. Food Res Int. 2016;89(Pt 1):90–116. doi: 10.1016/j.foodres.2016.08.032.
Suhendy H, Fidrianny I, Insanu M. Phytochemical compounds and pharmacological activities of Ipomoea batatas L.: an updated review. Pharmacia. 2023;70(4):1283–94. doi: 10.3897/pharmacia.70.e108922.
de Albuquerque TMR, Sampaio KB, de Souza EL. Sweet potato roots: unrevealing an old food as a source of health promoting bioactive compounds – a review. Trends Food Sci Technol. 2019;85:277–86. doi: 10.1016/j.tifs.2018.11.006.
de Albuquerque TMR, Borges CWP, Cavalcanti MT, dos Santos Lima M, Magnani M, de Souza EL. Potential prebiotic properties of flours from different varieties of sweet potato (Ipomoea batatas L.) roots cultivated in Northeastern Brazil. Food Biosci. 2020;36:100614. doi: 10.1016/j.fbio.2020.100614.
Arisanti CIS, Wirasuta IMAG, Musfiroh I, Ikram EHK, Muchtaridi M. Mechanism of anti-diabetic activity from sweet potato (Ipomoea batatas): a systematic review. Foods. 2023;12(14):2810. doi: 10.3390/foods12142810.
Ye J, Meng X, Yan C, Wang C. Effect of purple sweet potato anthocyanins on beta-amyloid-mediated PC-12 cells death by inhibition of oxidative stress. Neurochem Res. 2010;35(3):357–65. doi: 10.1007/s11064-009-0063-0.
Kim JK, Choi SJ, Cho HY, Kim YJ, Lim ST, Kim CJ, et al. Ipomoea batatas attenuates amyloid β peptide-induced neurotoxicity in ICR mice. J Med Food. 2011;14(3):304–9. doi: 10.1089/jmf.2010.0047.
Hyun K, Yeon-Gil K, Sushruta K. Protective effect of purple sweet potato (Ipomoea batatas Linn, Convolvulaceae) on neuroinflammatory responses in lipopolysaccharide-stimulated microglial cells. Trop J Pharm Res. 2014;13(8):1257–63. doi: 10.4314/tjpr.v13i8.9.
Adnyana IMO, Sudewi AR, Samatra DP, Suprapta DN. Neuroprotective effects of purple sweet potato Balinese cultivar in Wistar rats with ischemic stroke. Open Access Maced J Med Sci. 2018;6(11):1959–64. doi: 10.3889/oamjms.2018.435.
Akhtar N, Akram M, Daniyal M, Ahmad S. Evaluation of antidiabetic activity of Ipomoea batatas L. extract in alloxan-induced diabetic rats. Int J Immunopathol Pharmacol. 2018;32:2058738418814678. doi: 10.1177/2058738418814678.
Olabisi OO, Olusegun OF, Samuel O, Akinola MO, Oluwatosin BA. Anti-diabetic activity of Ipomoea batatas leaves extract: effects on hepatic enzymes in alloxan-induced diabetic rats. Res J Med Plant. 2015;9(5):227–33. doi: 10.3923/rjmp.2015.227.233.
Almoraie NM. The role of Ipomoea batatas leaves extract on the treatment of diabetes induced by streptozotocin. Pharmacophore. 2019;10(3):14–20.
Shih CK, Chen CM, Viola V, Shih LC, Chang PR, Liao SF, et al. White sweet potato ameliorates hyperglycemia and regenerates pancreatic islets in diabetic mice. Food Nutr Res. 2020;64:3609. doi: 10.29219/fnr.v64.3609.
Shagufta K, Naheed A, Khan S, Shumaila K, Tahir F, Muhammad A, et al. Anti-diabetic activity of aqueous extract of Ipomoea batatas L. in alloxan induced diabetic Wistar rats and its effects on biochemical parameters in diabetic rats. Pak J Pharm Sci. 2018;31(4 Suppl):1539–48. PMID:30058546.
Majid MF, Ijaz MW, Baig B, Nasir B, Khan MR, Haq I. Scientific validation of ethnomedicinal use of Ipomoea batatas L. Lam as aphrodisiac and gonadoprotective agent against bisphenol A induced testicular toxicity in male Sprague Dawley rats. Biomed Res Int. 2019;2019:8939854. doi: 10.1155/2019/8939854.
Oyagbemi AA, Omobowale TO, Saba AB. Gallic acid protects against cyclophosphamide-induced toxicity in testis and epididymis of rats. Andrologia. 2016;48(4):393–401. doi: 10.1111/and.12459.
Majid M, Nasir B, Zahra SS, Khan MR, Mirza B, Haq IU. Ipomoea batatas L. Lam ameliorates acute and chronic inflammations by suppressing inflammatory mediators: a comprehensive exploration using in vitro and in vivo models. BMC Complement Altern Med. 2018;18(1):216. doi: 10.1186/s12906-018-2279-5.
Pasha I, Arshad A, Ahmad F, Raza A. Antiulcerative potential of sweet potato (Ipomoea batatas) against aspirin-induced gastric ulcers in a rabbit model. Nutrition. 2022;103–104:111799. doi: 10.1016/j.nut.2022.111799.
Hermes D, Dudek DN, Maria MD, Horta LP, Lima EN, de Fátima Â, et al. In vivo wound healing and antiulcer properties of white sweet potato (Ipomoea batatas). J Adv Res. 2013;4(4):411–5. doi: 10.1016/j.jare.2012.06.001.
Panda V, Sonkamble M. Anti-ulcer activity of Ipomoea batatas tubers (sweet potato). Funct Foods Health Dis. 2012;2(3):48–61. doi: 10.31989/ffhd.v2i3.99.
Silva-Correa CR, Hilario-Vargas J, Villarreal-La Torre VE, Calderón-Peña AA, González-Siccha AD, Aspajo-Villalaz CL, et al. Potential anticancer activity of bioactive compounds from Ipomoea batatas. Pharmacogn J. 2022;14(3):650–59. doi: 10.5530/pj.2022.14.84.
Dossou-Yovo VR, Ghicha I, Baghrous S, Bouselham F, Rahmoune I, Filali H. Anticancer activity and toxicity of decoction of Ipomoea batatas leaves and Milicia excelsa roots used in cancer. J Drug Deliv Ther. 2025;15(4):126–32. doi: 10.22270/jddt.v15i4.7054.
Li Z, Yu Y, Wang M, et al. Anti-breast cancer activity of SPG-56 from sweet potato in MCF-7 bearing mice in situ through promoting apoptosis and inhibiting metastasis. Sci Rep. 2019;9:146. doi: 10.1038/s41598-018-29099-x.
Sugata M, Lin CY, Shih YC. Anti-inflammatory and anticancer activities of Taiwanese purple-fleshed sweet potatoes (Ipomoea batatas L. Lam) extracts. Biomed Res Int. 2015;2015:768093. doi: 10.1155/2015/768093.
Islam S. Antimicrobial activities of Ipomoea batatas (L.) leaf. J Food Agric Environ. 2008;6(1):14–17.
Mayasari D, Islami D, Oktariani E, Wulandari P. Phytochemical, antioxidant and antibacterial evaluations of Ipomoea batatas L. from Riau, Sumatera Island, Indonesia. Trop J Nat Prod Res. 2023;7(1):2157–62. doi: 10.26538/tjnpr/v7i1.11.
Stange RR, Midland SL, Holmes GJ, Sims JJ, Mayer RT. Constituents from the periderm and outer cortex of Ipomoea batatas with antifungal activity against Rhisopus stolonifer. Postharvest Biol Technol. 2001;23(2):85–92. doi: 10.1016/S0925-5214(01)00105-3.
Datta A, Sakshar S, Shubham P, Ritu K, Sourin M, Somnath M, et al. Phytochemical, antioxidant and in-vitro anti-inflammatory studies of peels of sweet potato (Ipomoea batatas). J Adv Zool. 2024;45(2):695–705. doi: 10.53555/jaz.v45i2.3985.
Jawi IM, Mahendra AN, Subawa AAN, Yasa IS, Gunawan WG. Comparison of antihypertensive and antioxidative effect of mahogany (Swietenia mahagoni) seed extract and purple sweet potato tuber extract on rodent model of hypertension. Biomed Pharmacol J. 2017;10(2):577–82. doi: 10.13005/bpj/1144.
Runnie I, Salleh MN, Mohamed S, Head RJ, Abeywardena MY. Vasorelaxation induced by common edible tropical plant extracts in isolated rat aorta and mesenteric vascular bed. J Ethnopharmacol. 2004;92(2–3):311–16. doi: 10.1016/j.jep.2004.03.019.
Panda V, Sonkamble M, Patil S. Wound healing activity of Ipomoea batatas tubers (sweet potato). Funct Foods Health Dis. 2011;1(10):403–15. doi: 10.31989/ffhd.v1i10.118.
Li C, Zhang L. In vivo anti-fatigue activity of total flavonoids from sweetpotato (Ipomoea batatas L.) leaf in mice. Indian J Biochem Biophys. 2013;50(4):326–29. PMID:24772953.
Ju JH, Hong-Sup Y, Hyun-Joon P, Mi-Young K, Hyeun-Kil S, Kun-Young P, et al. Anti-obesity and antioxidative effects of purple sweet potato extract in 3T3-L1 adipocytes in vitro. J Med Food. 2011;14(10):1–11. doi: 10.1089/jmf.2010.1450.
Joanne YHT, Zhixuan S, Dejian H. Resin glycosides in aerial parts of Ipomoea batatas are potent lipase inhibitors: potential upcycling of sweet potato by-products to combat obesity. Food Funct. 2022;13(9):5353–64. doi: 10.1039/D2FO00555G.
Sucharitha M, Kotesh M, Devika K, Naresh Y, Kiran M. Evaluation of diuretic activity of aqueous extract of Ipomoea batatas (L). Sch J App Med Sci. 2016;4(6A):1902–5. doi: 10.36347/sjams.2016.v04i06.006.
Wang L, Zhao Y, Zhou Q, Luo CL, Deng AP, Zhang ZC, Zhang JL. Characterisation and hepatoprotective activity of anthocyanins from purple sweet potato (Ipomoea batatas L. cultivar Eshu No. 8). J Food Drug Anal. 2017;25(3):607–18. doi: 10.1016/j.jfda.2016.10.009.
Kang H, Lee SG. Protective effect of purple sweet potato leaf (Ipomoea batatas Linn Convolvulaceae) against alcohol-induced liver damage in mice. Trop J Pharm Res. 2021;20(2):301–8. doi: 10.4314/tjpr.v20i2.12.
Boukhers I, Morel S, Kongolo J, Domingo R, Servent A, Ollier L, et al. Immunomodulatory and antioxidant properties of Ipomoea batatas flour and extracts obtained by green extraction. Curr Issues Mol Biol. 2023;45(9):6967–85. doi: 10.3390/cimb45090440.
Zhao G, Kan J, Li Z, Chen Z. Characterisation and immunostimulatory activity of an (1→6)-α-D-glucan from the root of Ipomoea batatas. Int Immunopharmacol. 2005;5(9):1436–45. doi: 10.1016/j.intimp.2005.03.012.
Mpiana PT, Misakabu FM, Yuma PM, Tshibangu DST, Ngbolua KN, Mwanyishay CL, et al. Antisickling activity and physico-chemical stability of anthocyanin extracts from Ipomoea batatas leaves. J Med Life. 2014;2(1):25–31.
Mahendra AN, Jawi IM, Astawa NM, Astawa P, Sutirta-Yasa IWP. Renoprotective effects of anthocyanins against uric acid-instigated injury: mini review with a special emphasis on purple sweet potato (Ipomoea batatas L.) anthocyanins. Biomed Pharmacol J. 2023;16(2):629–37. doi: 10.13005/bpj/2645.
Sathish R, Jeyabalan G. Anti-lithiatic effect of Ipomoea batatas (L) leaves and tuberous roots on ethylene glycol induced urolithiasis in rats. Res J Pharmacol Pharmacodyn. 2018;10(1):1–7. doi: 10.5958/2321-5836.2018.00001.0.
Ludvik B, Neuffer B, Pacini G. Efficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic subjects treated with diet. Diabetes Care. 2004;27(2):436–40. doi: 10.2337/diacare.27.2.436.
Ludvik B, Waldhäusl W, Prager R, Kautzky-Willer A, Pacini G. Mode of action of Ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism. 2003;52(7):875–80. doi: 10.1016/S0026-0495(03)00073-8.
Chen CM, Shih CK, Su YJ, Cheang KU, Lo SF, Li SC. Evaluation of white sweet potato tube-feeding formula in elderly diabetic patients: a randomised controlled trial. Nutr Metab. 2019;16:70. doi: 10.1186/s12986-019-0398-8.
Chen CM, Lin YL, Chen CY, Hsu CY, Shieh MJ, Liu JF. Consumption of purple sweet potato leaves decreases lipid peroxidation and DNA damage in humans. Asia Pac J Clin Nutr. 2008;17(3):408-14. PMID: 18818160.
Jongstra R, Mwangi MN, Burgos G, Zeder C, Low JW, Mzembe G, et al. Iron absorption from iron biofortified sweetpotato is higher than regular sweetpotato in Malawian women while iron absorption from regular and iron biofortified potatoes is high in Peruvian women. J Nutr. 2020;150(12):3094–102. doi: 10.1093/jn/nxaa267.
Hutabarat NC, Widyawati MN. The effect of sweet potato leaf decoction and iron tablet against increased hemoglobin levels in pregnant women. Indones J Health Res. 2018;1(2):59–65. doi: 10.32805/ijhr.2018.1.2.11.
Oki T, Kano M, Watanabe O, Goto K, Boelsma E, Ishikawa F, et al. Effect of consuming a purple fleshed sweet potato beverage on health related biomarkers and safety parameters in Caucasian subjects with elevated levels of blood pressure and liver function biomarkers: a 4 week, open label, non comparative trial. Biosci Microbiota Food Health. 2016;35(3):129–36. doi: 10.12938/bmfh.2015-026.
Suda I, Ishikawa F, Hatakeyama M, Miyawaki M, Kudo T, Hirano K, et al. Intake of purple sweet potato beverage effects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis. Eur J Clin Nutr. 2008;62(1):60–7. doi: 10.1038/sj.ejcn.1602674.
Shih CK, Chen CM, Hsiao TJ, Liu CW, Li SC. White sweet potato as meal replacement for overweight white collar workers: a randomised controlled trial. Nutrients. 2019;11(1):165. doi: 10.3390/nu11010165.
Eissa HA, Gabrial SGN, Nadir AS, Ramadan MT, Mohamed SS, Ibrahim WA. Egyptian batata (sweet potato: Ipomoea batatas Lam) juice as a functional food to relieve acid reflux and dyspepsia. Ann Rom Soc Cell Biol. 2021;25(2):4418–29.
Cipta NA, Fridayanti A, Gama SI, Wathoni N, Muta’ali M. Formulation and evaluation of hand and body lotion from purple sweet potato (Ipomoea batatas L.) peel extract and its antioxidant activity. Int J Appl Pharm. 2023;15(2):118–22. doi: 10.22159/ijap.2023.v15s2.22.
Wireko Manu FD, Ellis WO, Oduro I. Production of a non alcoholic beverage from sweet potato (Ipomoea batatas L.). Afr J Food Sci. 2010;4(4):180–3.
Mahalia LD, Supriyanto S, Syukri Y. Development of sweet potato (Ipomoea batatas Lamk.) as excipient in tablet formulation. J Public Health Res. 2022;9(2). doi: 10.4081/jphr.2020.1831.
Dipahayu D, Arifiyan D, Indramaya DM, Anggraeni S. Safety study of purple sweet potatoes leaves extract (Ipomoea batatas (L.) Lamk) Antin 3 variety as a sunscreen active ingredient on human skin. Int J Drug Deliv Technol. 2019;9(2):120-4. doi: 10.25258/ijddt.9.2.2.
Dewi NKSM, Ramona Y, Saraswati MR, Wihandani DM, Wirasuta IMAG. The potential of the flavonoid content of Ipomoea batatas L. as an alternative analog GLP 1 for diabetes type 2 treatment—Systematic review. Metabolites. 2024;14:29. doi: 10.3390/metabo14010029.
Lucienne ALNP, Cokorda ISA, Ni KSMD, Wirasuta IMAG. Formulation and evaluation of red sweet potato (Ipomoea batatas L.) leaf antidiabetic capsules. Fitofarmaka J Ilm Farm. 2024;14(2):77–86. doi: 10.33751/jf.v14i2.8.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).